IPO Listing: Senores Pharma Lists at a Premium of 53% on NSE

Shares of Senores Pharma made a strong debut on the bourses today. The company listed at ₹600 on the National Stock Exchange, a premium of 53.4%. On the BSE, it got listed at a premium of 51.8% at ₹593.7.

IPO Details

The IPO was subscribed 97.86 times. While the retail portion was subscribed by 93.16 times, NIIs and QIBs booked the shares by 100.35 times and 97.84 times respectively. The company raised ₹582.11 crore from investors.

IPO Review

Reliance Securities in an IPO note, “Senores Pharmaceuticals has adopted an inorganic growth through synergistic acquisitions, enhancing market share in USA and regulated markets, alliances for CMO/CDMO business, professional and dedicated management team for diverse business verticals augurs well for the company in the long term. Hence, we recommend a Subscribe to the issue.”